Multigene panel testing for hereditary breast/ovarian cancer risk assessment

[News]

Multigene testing of women negative for BRCA1 and BRCA2 found some of them harbored other harmful genetic mutations, most commonly moderate-risk breast and ovarian cancer genes and Lynch syndrome...

More... (http://www.medicalnewstoday.com/releases/298323.php)